1 study found for:    10961860 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sorafenib (BAY 43-9006) to Treat Children With Solid Tumors or Leukemias
Conditions: Refractory Solid Tumors;   Refractory Leukemias
Intervention: Drug: BAY 43-9006

Indicates status has not been verified in more than two years